🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
RATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in differe...
Status
Terminated
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2006-07
Trial ID
NCT00410774
Treatments Being Tested
Primary Objective: 1\. To assess resectability rate in patients undergoing...
Status
Completed
Location
U.T. M.D. Anderson Cancer Center
Start Date
2006-06
Trial ID
NCT00336648
Treatments Being Tested
This is a phase II study of Bevacizumab plus Temodar and Tarceva in patient...
Status
Completed
Location
University of California San Francisco
Start Date
2007-09
Trial ID
NCT00525525
Treatments Being Tested
Selected patients with peritoneal carcinomatosis (PC) from colorectal cance...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-09-21
Trial ID
NCT03161041
Treatments Being Tested
To compare outcomes between the CRS group and the control group in patients...
Status
Recruiting
Location
National Cancer Center, Korea
Start Date
2025-09-10
Trial ID
NCT07171528
Treatments Being Tested
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion cl...
Status
Recruiting
Location
Arizona Oncology Associates
Start Date
2020-07-14
Trial ID
NCT04485013
For patients with early- to mid-stage hepatocellular carcinoma (HCC), the f...
Status
Active Not Recruiting
Location
Tongji Hospital
Start Date
2025-02-10
Trial ID
NCT07009470
Treatments Being Tested
The primary aim of this study is to investigate whether the addition of the...
Status
Terminated
Location
Universitair Medisch Centrum Utrecht
Start Date
2006-12
Trial ID
NCT00394992
Treatments Being Tested
Primary Objective: * To demonstrate that re-challenge with an oxaliplatin ...
Status
Withdrawn
Location
Sanofi-Aventis Administrative Office
Start Date
2009-10
Trial ID
NCT00988897
Treatments Being Tested